GHTF Study Group 5 - Clinical Safety/Performance Documents
This page contains archived GHTF documents only. Not all documents generated by GHTF are featured in this archive. For a list of final GHTF documents, see the GHTF final documents page.
Technical documents
GHTF code: GHTF/SG5/N3:2010 - Date posted: 12 February 2010
GHTF SG5 - Clinical Investigations - February 2010
GHTF code: SG5-N2R8:2007 - Date posted: 1 May 2007
GHTF SG5 - Clinical Evaluation - May 2007
GHTF code: SG5-N1R8 - Date posted: 1 May 2007
GHTF SG5 - Clinical Evidence - Key Definitions and Concepts - May 2007
GHTF code: GHTF SG5(PD)/N2R7 - Date posted: 26 April 2006
GHTF SG5 - Clinical Evaluation
GHTF code: GHTF SG5(PD)/N1R7 - Date posted: 26 April 2006
GHTF SG5 - Clinical Evidence - Key Definitions and Concepts
Meeting dates and meeting minutes
Date: 8 May 2007, Location: California, USA
GHTF SG5 - Meeting Minutes - May 2007 California
Date: 19 May 2008, Location: Tokyo, Japan
GHTF SG5 - Meeting Minutes - May 2008 Tokyo
Date: 1 October 2007, Location: Washington DC, USA
GHTF SG5 - Meeting Minutes - October 2007 Washington
Date: 7 February 2007, Location: Hawaii, USA
GHTF SG5 - Meeting Minutes - February 2007 Hawaii
Date: 3-4 October 2006, Location: Toronto, Canada
GHTF SG5 - Meeting Minutes - October 2006 Toronto
Date: 27-28 June 2006, Location: Lubeck, Germany
GHTF SG5 - Meeting Minutes - June 2006 Lubeck
Date: 26 April 2006, Location: California, USA
GHTF SG5 - Meeting Minutes - April 2006 California
Date: 16 September 2005, Location: Maryland, USA
GHTF SG5 - Clinical Evidence - Overview of SG5 Presentation- September 2005 Maryland
Date: 14 September 2005, Location: Maryland, USA
GHTF SG5 - Meeting Minutes - September 2005 Maryland
Date: 10 May 2005, Location: London, United Kingdom
GHTF SG5 - Meeting Minutes - May 2005 London
Date: 17 January 2005, Location: Canberra, Australia
GHTF SG5 - Meeting Minutes - January 2005 Canberra